Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How common is inflammatory marker-negative disease in giant cell arteritis?

Literature DB >> 23099915

How common is inflammatory marker-negative disease in giant cell arteritis?

S L Levy, A D Bull, A R Nestel.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2012 PMID： 23099915 PMCID： PMC3545382 DOI： 10.1038/eye.2012.223

Source DB: PubMed Journal: Eye (Lond) ISSN： 0950-222X Impact factor: 3.775

× No keyword cloud information.

6 in total

Review 1. Epidemiology of biopsy-positive giant cell arteritis: an overview.

Authors: E Nordborg
Journal: Clin Exp Rheumatol Date: 2000 Jul-Aug Impact factor: 4.473

2. Giant cell arteritis with a normal ESR and CRP.

Authors: Thomas R G Poole; Elizabeth M Graham; Sebastian B Lucas
Journal: Eye (Lond) Date: 2003-01 Impact factor: 3.775

3. Giant cell arteritis: validity and reliability of various diagnostic criteria.

Authors: S S Hayreh; P A Podhajsky; R Raman; B Zimmerman
Journal: Am J Ophthalmol Date: 1997-03 Impact factor: 5.258

4. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.

Authors: Mona Parikh; Neil R Miller; Andrew G Lee; Peter J Savino; M Noel Vacarezza; Wayne Cornblath; Eric Eggenberger; Aileen Antonio-Santos; Karl Golnik; Randy Kardon; Michael Wall
Journal: Ophthalmology Date: 2006-08-01 Impact factor: 12.079

5. Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis.

Authors: Ryan Hegg; Andrew G Lee; Nathan T Tagg; M Bridget Zimmerman
Journal: J Neuroophthalmol Date: 2011-06 Impact factor: 3.042

6. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation.

Authors: Robert Kleemann; Philippe P Gervois; Lars Verschuren; Bart Staels; Hans M G Princen; Teake Kooistra
Journal: Blood Date: 2002-08-29 Impact factor: 22.113

6 in total

5 in total

How common is inflammatory marker-negative disease in giant cell arteritis?

Review 1. Epidemiology of biopsy-positive giant cell arteritis: an overview.

2. Giant cell arteritis with a normal ESR and CRP.

3. Giant cell arteritis: validity and reliability of various diagnostic criteria.

4. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.

5. Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis.

6. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation.

1. Giant cell arteritis with normal ESR and/or CRP is rare, but not unique!

2. Response to Grzybowski and Justynska.

3. Comment on: How common is inflammatory marker-negative disease in giant cell arteritis?

4. Response to comment on: how common is inflammatory marker-negative disease in giant cell arteritis?

5. 14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.